Human Genome Epidemiology Literature Finder
|
Records 1 - 21 (of 21 Records) |
| Query Trace: Ovarian Neoplasms and VEGF[original query] |
|---|
| Heparanase gene haplotype (CGC) is associated with stage of disease in patients with ovarian carcinoma. Cancer science 2007 Jun 98 (6): 844-9. Ralph Shirley, Brenchley Paul E C, Summers Angela, Rosa Daniela D, Swindell Ric, Jayson Gordon |
| Vascular endothelial growth factor gene polymorphisms in ovarian cancer. Gynecologic oncology 2007 May 105 (2): 385-9. Polterauer Stephan, Grimm Christoph, Mustea Alexander, Concin Nicole, Tanner Berno, Thiel Falk, Heinze Georg, Reinthaller Alexander, Zeillinger Robert, Hefler Lukas |
| Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Feb 13 (3): 898-901. Hefler Lukas A, Mustea Alexander, Könsgen Dominique, Concin Nicole, Tanner Berno, Strick Reiner, Heinze Georg, Grimm Christoph, Schuster Eva, Tempfer Clemens, Reinthaller Alexander, Zeillinger Robe |
| Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 14 (22): 7554-63. Schultheis Anne M, Lurje Georg, Rhodes Katrin E, Zhang Wu, Yang Dongyun, Garcia Agustin A, Morgan Robert, Gandara David, Scudder Sidney, Oza Amit, Hirte Hal, Fleming Gini, Roman Lynda, Lenz Heinz-Jos |
| The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer letters 2008 Apr 262 (1): 71-6. Jakubowska Anna, Gronwald Jacek, Menkiszak Janusz, Górski Bohdan, Huzarski Tomasz, Byrski Tomasz, Edler Lutz, Lubi?ski Jan, Scott Rodney J, Hamann U |
| Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival. Gynecologic oncology 2010 Dec 119 (3): 479-83. Lose Felicity, Nagle Christina M, O'Mara Tracy, Batra Jyotsna, Bolton Kelly L, Song Honglin, Ramus Susan J, Gentry-Maharaj Aleksandra, Menon Usha, Gayther Simon A, Pharoah Paul D P, Kedda Mary-Anne, Spurdle Amanda |
| The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab. Gynecologic oncology 2010 Aug 118 (2): 167-71. Smerdel M P, Steffensen K D, Waldstrøm M, Brandslund I, Jakobsen |
| Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010 Jul 20 (5): 717-23. Li Yan, Wang Yan, Kang Shan, Wang Na, Zhou Rong-Miao, Duan Ya-Nan, Sun Dong-Lan, Qin Jing-Jing, Zhao Wei, Zhao Li |
| The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer. Gynecologic oncology 2010 Apr 117 (1): 109-16. Steffensen K D, Waldstrøm M, Brandslund Ivan, Jakobsen |
| Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer. Journal of cancer research and clinical oncology 2015 Jan 141 (1): 69-73. Rinck-Junior José Augusto, Oliveira Cristiane, Lourenço Gustavo Jacob, Sagarra Regina Aparecida Martinho, Derchain Sophie Françoise Mauricette, Segalla José Getulio, Lima Carmen Silvia Pass |
| Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial. The pharmacogenomics journal 2015 Jul . He Y J, Winham S J, Hoskins J M, Glass S, Paul J, Brown R, Motsinger-Reif A, McLeod H |
| CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer. Frontiers in oncology 2015 5 123. Lee Jung-Min, Trepel Jane B, Choyke Peter, Cao Liang, Sissung Tristan, Houston Nicole, Yu Minshu, Figg William D, Turkbey Ismail Baris, Steinberg Seth M, Lee Min-Jung, Ivy S Percy, Liu Joyce F, Matulonis Ursula A, Kohn Elise |
| Three Polymorphisms of Vascular Endothelial Growth Factor (+936C > T, -460C > T, and -2578C > A) and Their Susceptibility to Ovarian Cancer: A Meta-Analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2015 Jun 25 (5): 779-85. Zhang Xiaolian, Qin Jinchun, Qin Aipi |
| VEGF gene polymorphisms and outcome of epithelial ovarian cancer patients. Future oncology (London, England) 2016 Oct . Camerin Gabriela Ribeiro, Brito Angelo Borsarelli Carvalho, Vassallo José, Derchain Sophie Françoise Mauricette, Lima Carmen Silvia Pass |
| The c.1085A>G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of Macrophages. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jul . Yeh Yu-Min, Hsu Shan-Ju, Lin Peng-Chan, Hsu Keng-Fu, Wu Pei-Ying, Su Wu-Chou, Chang Jang-Yang, Shen Meng- |
| Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2017 Jun . González-Palomares Blanca, Coronado Martín Pluvio J, Maestro de Las Casas María Luisa, Veganzones de Castro Silvia, Rafael Fernández Sara, Vidaurreta Lázaro Marta, De la Orden García Virginia, Vidart Aragon Jose Anton |
| Association of four genetic polymorphisms in the vascular endothelial growth factor-A gene and development of ovarian cancer: a meta-analysis. Oncotarget 2017 Sep 8 (42): 73063-73078. Xu Chao-Huan, He Zhong-Hui, Xu Ho |
| Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study). British journal of cancer 2018 6 119 (3): 330-338. Ruscito Ilary, Cacsire Castillo-Tong Dan, Vergote Ignace, Ignat Iulia, Stanske Mandy, Vanderstichele Adriaan, Glajzer Jacek, Kulbe Hagen, Trillsch Fabian, Mustea Alexander, Kreuzinger Caroline, Benedetti Panici Pierluigi, Gourley Charlie, Gabra Hani, Nuti Marianna, Taube Eliane T, Kessler Mirjana, Sehouli Jalid, Darb-Esfahani Silvia, Braicu Elena Ioa |
| [The vascular endothelial growth factor in patients with advanced ovarian cancer on the background of chemotherapy according to the AP scheme.]. Klinicheskaia laboratornaia diagnostika 2019 2 63 (9): 543-548. Abakumova T V, Gening S O, Dolgova D R, Gening T P, Antoneeva I I, Poludnyakova L V, Kuznetsova T I, Dergunova Yu A, Panchenko E |
| VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status. Journal of hematology & oncology 2021 11 14 (1): 186. Bizzaro Francesca, Fuso Nerini Ilaria, Taylor Molly A, Anastasia Alessia, Russo Massimo, Damia Giovanna, Guffanti Federica, Guana Francesca, Ostano Paola, Minoli Lucia, Hattersley Maureen M, Arnold Stephanie, Ramos-Montoya Antonio, Williamson Stuart C, Galbiati Alessandro, Urosevic Jelena, Leo Elisabetta, Cavallaro Ugo, Ghilardi Carmen, Barry Simon T, Bani Maria Rosa, Giavazzi Raffael |
| c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial. BMC medicine 2022 Feb 20 (1): 59. Morgan Robert D, Ferreras Cristina, Peset Isabel, Avizienyte Egle, Renehan Andrew G, Edmondson Richard J, Murphy Alexander D, Nicum Shibani, Van Brussel Thomas, Clamp Andrew R, Lambrechts Diether, Zhou Cong, Jayson Gordon |
- Page last reviewed:Feb 1, 2024
- Content source: